Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Cellular Physiology|September 27, 2007
Gab2 requires membrane targeting and the Met binding motif to promote lamellipodia, cell scatter, and epithelial morphogenesis downstream from the Met receptorMelanie M Frigault, Monica A Naujokas, Morag Park
Molecular and Cellular Biology|March 18, 2009
Pak4, a novel Gab1 binding partner, modulates cell migration and invasion by the Met receptorGrigorios N Paliouras, Monica A Naujokas, Morag Park
Molecular Biology of the Cell|April 11, 2003
Membrane targeting of Grb2-associated binder-1 (Gab1) scaffolding protein through Src myristoylation sequence substitutes for Gab1 pleckstrin homology domain and switches an epidermal growth factor response to an invasive morphogenic programChristiane R Maroun, Monica A Naujokas, Morag Park
Molecular Biology of the Cell|June 12, 2002
Distinct recruitment and function of Gab1 and Gab2 in Met receptor-mediated epithelial morphogenesisLisa S Lock, Christiane R Maroun, Monica A Naujokas, et al.
Oncogene|March 16, 2002
Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasisCaroline Saucier, Vasilios Papavasiliou, Alexander Palazzo, et al.
Molecular and Cellular Biology|October 18, 2005
Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylationJasmine V Abella, Pascal Peschard, Monica A Naujokas, et al.
Molecular Biology of the Cell|November 19, 2004
HGF converts ErbB2/Neu epithelial morphogenesis to cell invasionHanane Khoury, Monica A Naujokas, Dongmei Zuo, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2004
The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesisCaroline Saucier, Hanane Khoury, Ka-Man Venus Lai, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2013
Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancerJennifer F Knight, Robert Lesurf, Hong Zhao, et al.
Pageof 1